Early statin therapy in patients with acute coronary syndrome

Hellenic Journal of Cardiology

Volumn 46, Issue 1, 2005, Pages 5-8

  Liberopoulos, Evagelos N ^a   Daskalopoulou, Stella S ^a   Mikhailidis, Dimitri P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Acute coronary syndrome; Atherosclerosis; C reactive protein; Cholesterol lowering; Low density lipoprotein cholesterol; Statins

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; COLESTYRAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; PLACEBO; PRAVASTATIN; SIMVASTATIN;

ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; ECG ABNORMALITY; HEART ARREST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MORTALITY; PLEIOTROPY; PROPHYLAXIS; REVIEW; RISK REDUCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS; AGED; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; HOSPITALIZATION; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME; UNITED KINGDOM;

AGED; ANGINA, UNSTABLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GREAT BRITAIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 17844367826     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Kinlay S, Ganz P: Early statin therapy in acute coronary syndromes. Semin Vasc Biol 2003; 3: 419-424.
2. Goyal A, Petersen JL, Mahaffey KW: The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromes. Curr Cardiol Rep 2004; 6: 300-307.
3. Schwartz GG, Olsson AG, Ezekowitz MD, et al: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001; 285: 1711-1718.
4. Olsson AG, Schwartz GG: Early initiation of treatment with statins in acute coronary syndromes. Ann Med 2002; 34: 37-41.
5. Thompson PL, Meredith I, Amerena J, et al: Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravasvtatin in Acute Coronary Treatment (PACT) trial. Am Heart J 2004; 148: e2.
6. Arntz HR, Agrawal R, Wunderlich W, et al: Beneficial effects of pravastatin (+/- cholestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). Am J Cardiol 2000; 86: 1293-1298.
7. Pasceri V, Patti G, Nusca A, et al: Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA study. Circulation 2004; 110: 674-678.
8. de Lemos JA, Blazing MA, Wiviott SD, et al: Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 2004; 292: 1365-1367.
9. Cannon CP, Braunwauld E, McCabe CH, et al: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.
10. Ray KK, Cannon CP: Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology. Curr Opin Lipidiol 2004; 15: 637-643.
11. Topol EJ: Intensive statin therapy - A sea change in cardiovascular prevention. N Engl J Med 2004; 350: 1562-1564.
12. Walter DH: Insights into early and rapid effects of statin therapy after coronary intervention. Curr Pharm Des 2004; 10: 369-373.
13. de Denus S, Spinler SA: Early statin therapy for acute coronary syndromes. Ann Pharmacother 2002; 36: 1749-1758.
14. Tsiara S, Elisaf M, Mikhailidis DP: Early vascular benefits of statin therapy. Curr Med Res Opin 2003; 19: 540-556.
15. Muhlestein JB, Anderson JL, Home BD, et al: Early effects of statins in patients with coronary artery disease and high Creactive protein. Am J Cardiol 2004; 94: 1107-1112.
16. Wassmann S, Faul A, Hennen B, et al: Rapid effect of 3-hy-droxy-3- methylglutaryl coenzyme A reductase inhibition on coronary endothelial function. Circ Res 2003; 93: e98-e103.
17. Krishnamoorthy KM, Nair K: Role of statins in acute coronary syndromes. Acta Cardiol 2004; 59: 547-553.
18. Wolfrum S, Dendorfer A, Schutt M, et al: Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway. J Cardiovasc Pharmacol 2004; 44: 348-355.
19. Kinlay S, Schwartz GG, Olsson AG, et al: Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation 2004; 110: 386-391.
20. Okazaki S, Yokoyama T, Miyauchi K, et al: Early statin treatment in patients with acute coronary syndrome. Circulation 2004; 110: 1061-1068.
21. Schomig A, Mehilli J, Holle H, et al.: Statin treatment following coronary artery stenting and one-year survival. J Am Coll Cardiol 2002; 40: 854-861.
22. Serruys PWJ, Feyter P, Macaya C, et al: Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention. A randomized controlled trial. JAMA 2002; 287: 3215-3222.
23. Saab FA, Eagle KA, Kline-Rogers E, et al: Comparison of outcomes in acute coronary syndromes in patients receiving statins within 24 hours of onset versus at later times. Am J Cardiol 2004; 94: 1166-1168.
24. Spencer FA, Fonarow GC, Frederick PD, et al: Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. Arch Intern Med 2004; 164: 2162-2168.
25. Heeschen C, Hamm CW, Laufs U, et al: Withdrawal of statins increases events rates in patients with acute coronary syndromes. Circulation 2002; 105: 1446-1452.
26. Spencer FA, Allegrone J, Goldberg RJ, et al: Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med 2004; 140: 857-866.
27. Aronow HD, Topol EJ, Roe MT, et al: Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet 2001; 357: 1063-1068.
28. Stenestrand U, Wallentin L: Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001; 285: 430-436.
29. Fang CH, Li JJ, Hui RT: Statin, like aspirin, should be given as early as possible in patients with acute coronary syndromes. Med Hypotheses 2005; 64: 192-196.